
Find out more about how timely shared decision-making discussions can help address unmet needs for women of childbearing age.
Professor Xenofon Baraliakos is the Head of Rheumatology at the Rheumazentrum Ruhrgebiet, Herne, Germany, and Professor for Internal Medicine and Rheumatology at the Ruhr-University Bochum, Germany.
He studied human medicine at the University of Magdeburg, Berlin, Germany, and received his PhD degree in 2005. Professor Baraliakos was awarded his official Board Degree in orthopaedic surgery in 2007, and in internal medicine and rheumatology in 2014. His research interests include clinical and academic research in the field of spondyloarthritis, with special emphasis on imaging outcomes and treatment of the disease.
Among others, Professor Baraliakos won the European Workshop for Rheumatology Research (EWRR) Award in 2005, the European Alliance of Associations for Rheumatology (EULAR) Young Investigator Award in 2006 and 2008, the German Patient’s AS Society Award in 2010 and the Award for Excellence in Clinical Research from the European Society for Clinical Investigations (ESCI) in 2014.
Professor Baraliakos is the current president of the Assessment of Spondyloarthritis International Society (ASAS) and past Chair of the EULAR standing committee for musculoskeletal imaging. He also acts as a reviewer and is an associate editor in a number of major rheumatological journals.
Accompany Dr Ann-Sophie De Craemer as she discusses management options for a patient with axSpA exhibiting few symptoms.
Work through the challenges in diagnosing suspected axSpA in two patient cases with Dr Michael Nissen and Dr Philipp Julian Bosch.
Join Dr Lykke Midtbøll Ørnbjerg as she explores the value of registry data for informing clinical practice in axSpA.
Watch Dr Floris van Gaalen explore whether early diagnosis of axSpA is possible, drawing on findings from the SPACE cohort.1
Find out more about how timely shared decision-making discussions can help address unmet needs for women of childbearing age.
Accompany Dr William Tillett and Dr Fabian Proft as they explore the approaches and challenges of managing D2T patients with PsA.